TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Clinical trials for TRANSFORMED FOLLICULAR LYMPHOMA (TFL) explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED FOLLICULAR LYMPHOMA (TFL) trials appear
Sign up with your email to follow new studies for TRANSFORMED FOLLICULAR LYMPHOMA (TFL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy trial offers hope for lymphoma patients who have run out of options
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy called TC011 in adults whose large B-cell lymphoma has come back or hasn't responded to standard treatments. Doctors will collect a patient's own T-cells, genetically modify them in a lab to target cancer, and i…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test 'Ready-Made' immune cell therapy for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a new type of cancer treatment called P-CD19CD20-ALLO1 in adults with specific B-cell lymphomas that have come back or not responded to standard therapies. The treatment involves giving patients a single infusion of specially engine…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC